New Delhi: The Government of India continues to expand Jan Aushadhi Kendras to improve access to affordable healthcare. Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, these centres provide quality generic medicines at significantly lower prices.
Currently, over 18,646 Jan Aushadhi Kendras are operational across the country. As a result, patients can access medicines at rates that are 50% to 80% cheaper than branded alternatives.
Affordable medicines reach more people
The Jan Aushadhi Kendras network has grown rapidly in recent years. During the financial year 2024–25 alone, more than 4,100 new centres were opened.
Moreover, total sales reached ₹2,022.47 crore, indicating strong demand for low-cost medicines. This expansion has helped reduce out-of-pocket healthcare expenses for many families.
Wide range of medicines and products
The scheme offers a comprehensive product basket of over 2,100 medicines and 300 medical consumables. These include treatments for cardiovascular diseases, diabetes, infections, and other major health conditions.
In addition, more than 850 medicines for chronic and non-communicable diseases are available. Therefore, the initiative plays a key role in long-term disease management.
Strong supply chain ensures availability
To maintain consistent supply, the government has developed a robust logistics network. This includes warehouses, distributors, and an IT-enabled monitoring system.
Furthermore, authorities regularly track demand for fast-moving medicines. They have also introduced incentives for store owners to maintain stocks of commonly used drugs.
Boost to employment and entrepreneurship
Jan Aushadhi Kendras also create self-employment opportunities. The government follows a franchise-like model that allows individuals, NGOs, and companies to open centres.
Eligible applicants must have pharmacy qualifications or employ a certified pharmacist. As a result, the scheme supports both healthcare access and job creation.
Future expansion plans
The government aims to increase the number of Jan Aushadhi Kendras to 25,000 by March 2027. This expansion will further strengthen the availability of affordable medicines nationwide.
Overall, the initiative continues to improve healthcare accessibility. By promoting generic medicines, it ensures that quality treatment remains within reach for all citizens.
